Application of Magnetic Resonance Fat-Free Imaging

Stopped early

Conditions studied: Sarcoma

In brief

Magnetic resonance imaging (MRI) is presently the best study for assessing the size and extent of the patient's sarcoma. Many sarcomas contain fat that can interfere with the accuracy of sarcoma detection. The investigators have developed a new MRI method that can suppress all the fat signals in the patient's tumor and this may improve the investigators' ability to see the patient's sarcoma. The purpose of this study is to determine if the investigators' new fat-free imaging methods provides them with images that are better than, equal to, or worse than those images obtained by standard MRI methods. This study may help the investigators develop a more accurate MRI examination.

Key facts

Study ID

NCT00944476

Run by

Memorial Sloan Kettering Cancer Center

People needed

2

Starts

2009-07-01

Last updated by the study team

2014-05-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participant is capable of providing verbal consent.
• 18 years of age or older.
• Participants will belong to one of the following two categories:
• Patient with a known or suspected soft tissue sarcoma of the extremity or trunk who is/will be scheduled for an MRI scan as part of their routine care, -OR--
• Volunteer with no history of sarcoma.

Where it is running

• Memorial Sloan-Kettering CancerCenter — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.